Vimarsana
Biggest News Aggregation in the World

Page 3 - Nancy Simonian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nancy Simonian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nancy Simonian Today - Breaking & Trending Today

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update - Vimarsana News

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

-- On track to announce initial randomized data from SELECT-AML-1 trial in 4Q 2023 -- -- Expect to complete enrollment of 190 patients in SELECT-MDS-1 trial in 4Q 2023; pivotal CR data expected in...

CURE HOSTS "AI FOR GOOD" SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5 - Vimarsana News

CURE HOSTS "AI FOR GOOD" SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5

/PRNewswire/ -- Cure®, a healthcare innovation campus in New York City, today announced a one-of-a-kind Super Session featuring experts focused on leveraging...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript - Vimarsana News

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. [Operator Instructions].

Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update - Vimarsana News

Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update

-- On track to complete enrollment of 190 patients in 4Q 2023, with pivotal complete response data from SELECT-MDS-1 expected in 3Q 2024 -- -- Amended SELECT-MDS-1 study to add overall survival as... | May 10, 2023

Syros closes $60M merger with Bedminster's TYME - Vimarsana News

Syros closes $60M merger with Bedminster's TYME

Stockholders of Syros Pharmaceuticals and Bedminster’s TYME Technologies approved plans for a previously announced $60 million merger.

Source: njbiz.com